Source: AllCells Blog

AllCells Blog Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom: Recap of the Allogeneic Cell Therapies Summit 2023

The field of cell and gene therapy (CGT) is undergoing a significant transformation, with a notable shift towards allogeneic platforms. Placing a spotlight on what has been deemed the ‘future […] The post Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom: Recap of the Allogeneic Cell Therapies Summit 2023 appeared first on AllCells.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jay Tong's photo - Chairman & CEO of AllCells

Chairman & CEO

Jay Tong

CEO Approval Rating

84/100

Read more